How to buy Ripotinib

Repotrectinib (Repotrectinib), a targeted drug for the treatment of ROS1 or NTRK fusion gene-positive non-small cell lung cancer, has been approved for marketing in China, becoming another important development in the field of tumor molecular targeted therapy. At present, repotinib can not only be purchased through formal channels in China, but has also been included in the medical insurance catalog, providing more patients with affordable treatment options.

The most direct way to purchase Ripotinib in China is through hospital pharmacies or qualified drug sales platforms. After the patient is diagnosed as positive for ROS1 or NTRK fusion, the oncologist will issue a prescription and purchase the drug at the hospital pharmacy or medical insurance cooperation platform with the prescription. The specifications of the domestically marketed Ripotinib are 40mg*120 capsules/box, and the price per box is more than 5,000 yuan. Depending on the medical insurance policy of the specific region, some patients can enjoy reimbursement, and the personal out-of-pocket rate is significantly reduced. Coverage by medical insurance means that if patients meet the policy conditions, their financial burden will be significantly reduced during treatment with repotinib.

In addition to original drugs, some patients will also consider overseas channels, especially generic versions in Laos, India and other regions. Among them, Lao generic drugs are relatively well-known, and the price is generally more than 2,000 yuan per box. They are close to the original drugs in terms of ingredients and bioequivalence. These generic drugs are usually obtained throughoverseas platforms or cross-border medical services. Although they are cheap, you must be careful when choosing such drugs to ensure that the products you purchase come from legitimate sources and avoid buying fake drugs or non-standard preparations.

Overall, the domestic launch and medical insurance coverage of Ripotinib have brought patients a more convenient and standardized treatment path. Regardless of whether you choose original drugs or generic drugs, you must manage your medication under the guidance of a doctor and purchase it on a legal and compliant platform to ensure drug quality and treatment safety. Conducting ROS1 or NTRK fusion gene testing before medication is a prerequisite for ensuring the efficacy of targeted drugs. Patients should actively cooperate with the screening to ensure accurate treatment.

Reference materials:https://www.drugs.com/mtm/repotrectinib.html